Healthtech Startups

Poxel is a clinical-stage biopharmaceutical company developing treatments for chronic metabolic diseases, including metabolic dysfunction-associated steatohepatitis and rare genetic disorders. The company is advancing drug candidates targeting metabolic pathways and has one approved product marketed in Japan.

1 investor

Medical device company for long-segment femoropopliteal disease; sold to Endologix in 2021.

1 investor

Pr3vent develops a platform for newborn vision screening to detect and prevent avoidable vision loss and blindness in infants. It targets infant eye health with assessments aimed at improving children's long-term vision outcomes.

1 investor

Waystar provides an AI-powered software platform that helps healthcare providers manage the revenue cycle, including insurance benefit verification, prior authorization, and payment processing. The platform uses agentic and generative AI to automate tasks, reduce claim denials, and accelerate reimbursement for healthcare organizations.

1 investor

PracticeTek is a software and services company that builds SaaS platforms for outpatient healthcare clinics, including dental, orthodontics, optometry, chiropractic, physical therapy, dermatology, and medical spas. It operates a group of brands aimed at improving patient experience and simplifying the business operations of these practices.

1 investor

Prana Surgical develops less invasive tissue sampling technology aimed at obtaining sufficient tissue for accurate diagnosis, including genetic and molecular analysis, as an alternative to needle biopsy or surgical resection. It targets earlier, minimally invasive options for disease management in the medical device field.

1 investor

Praxis Packaging provides contract manufacturing services for pharmaceutical products, including solid dose bottling, blister packaging, liquid/cream/paste filling, and secondary packaging solutions for both prescription and over-the-counter medications in FDA and cGMP-compliant facilities.

1 investor

Praxisflow provides a patient communication platform for medical practices, clinics, and practice networks that combines AI automation, human support, and ongoing process integration to handle patient inquiries at scale. The service manages incoming requests across channels and automates routine tasks while routing complex cases to trained staff or practice teams.

1 investor

PRCXI manufactures laboratory equipment including oscillating incubators, shakers, and magnetic stirrers for scientific and research applications.

1 investor

Prealize develops AI and machine learning solutions for healthcare providers and health plans to enable proactive, prediction-driven care rather than reactive treatment. The company serves health systems and insurers seeking to optimize clinical outcomes and operations through predictive analytics.

1 investor

Preamble provides proactive, personalized health management combining comprehensive diagnostics (100+ biomarker blood panels, DEXA body composition, cardiac and fitness assessments), physician-interpreted health reports, and long-term coaching to extend clients' healthspan and lifespan. It offers membership-based preventive care that complements primary care for individuals focused on longevity and optimizing their health.

1 investor

PreciPoint develops digital microscopy systems, including a live digital microscope for rapid on-site sample evaluation. Its products serve laboratory and pathology settings.

1 investor

PreciseMDX offers an AI-driven platform for clinical and diagnostic laboratories that digitizes and automates lab order intake, converting handwritten requisitions, insurance cards, and IDs into structured data. It handles order management, verifies physician signatures, cross-maps lab codes, and provides analytics to reduce manual data entry and errors.

1 investor

Precision provides data analytics, statistical modeling, and market sizing services to B2B manufacturers, distributors, and wholesalers to support sales growth, pricing optimization, and M&A due diligence. It uses proprietary end-user transaction data feeds to deliver customized insights across industries, segments, and channels.

1 investor

PrecisionBiotics develops food supplements containing specific bacterial strains aimed at supporting gut health and the microbiome for consumers and clinicians, alongside educational resources on gut health. The company originated from microbiome research with the APC Microbiome Institute at UCC in Ireland and is now part of the Novonesis Group.

1 investor

PrecisionCare AI develops sensing technology and analytics for physical therapy to provide objective measurement of soft tissue treatment. The platform serves clinicians and health systems seeking to improve therapeutic precision and outcomes at scale.

1 investor

Precision Cell Systems is a company that provides products and services related to genomics and cell/biology research, offering resources, webinars, and product ordering through its website. The available page is a privacy policy and does not describe the specific products in detail.

1 investor

PrecisionOS provides immersive VR surgical training that uses AI to adapt to each learner, identifying strengths and weaknesses to personalize practice and performance analytics. It serves surgeons, healthcare providers, and medical institutions seeking measurable, realistic medical education and mentorship.

1 investor

PrecisionPhage develops computational and laboratory solutions for bacteriophage research to address antimicrobial resistance. The company creates bioinformatics tools and phage-based technologies intended for healthcare and biotech applications globally.

1 investor

PRECISIS develops bioelectronic therapies for neurological conditions, including EASEE, a minimally invasive neurostimulation system implanted under the scalp to treat drug-resistant focal epilepsy without brain surgery. The company targets patients with medication-resistant epilepsy and the medical professionals who treat them.

1 investor

Precuro offers Cognitive Risk Intelligence (CRI), a non-clinical assessment that measures how individuals respond to pressure and uncertainty and turns those patterns into a forward-looking behavioral signal predicting claim duration, cost, and complexity. It serves insurers, captives, and reinsurers, with primary applications in disability insurance and workers' compensation across claims triage, underwriting, and portfolio-level risk analysis.

1 investor

Predictheon develops data-analysis software that predicts adverse medical events, aimed at improving patient safety for clinicians in the perioperative (surgical) care setting.

1 investor

PredictionHealth's solutions have been rebranded as Prompt Sidekick and Prompt Insight, with the site redirecting visitors to prompthealth.com. The page itself provides no substantive detail about what the company builds or whom it serves.

1 investor

DrugPatentWatch provides biopharmaceutical intelligence drawn from primary sources such as the USPTO, FDA Orange Book, ANDA filings, litigation records, and patent registers across 134 countries, covering drug patents, pipelines, litigation, and pricing. It serves pharmaceutical professionals including generics manufacturers, biotech firms, and distributors, offering continuously updated, exportable data for competitive and market analysis.

1 investor